PRIMECAP Management trim Allogene Therapeutics, Inc.
PRIMECAP Management trim $13.2M of disclosed value in Allogene Therapeutics, Inc..
Signal
Investor Move
Action
Trim
Capital
$13.2M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.